LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Rosuvastatin potentiates the thyrotropin‐lowering effect of metformin in men with non‐autoimmune subclinical hypothyroidism and prediabetes

Photo by ronaldlangeveld from unsplash

Metformin treatment decreases thyrotropin levels in individuals with hypothyroidism and this effect seems to be mediated by the 5′‐adenosine monophosphate‐activated protein kinase pathway in the pituitary. The activity of this… Click to show full abstract

Metformin treatment decreases thyrotropin levels in individuals with hypothyroidism and this effect seems to be mediated by the 5′‐adenosine monophosphate‐activated protein kinase pathway in the pituitary. The activity of this pathway is also stimulated by statins. The current study was aimed at investigating whether the impact of metformin on hypothalamic–pituitary–thyroid axis activity is affected by statin use.

Keywords: effect; thyrotropin lowering; rosuvastatin potentiates; lowering effect; hypothyroidism; potentiates thyrotropin

Journal Title: Journal of Clinical Pharmacy and Therapeutics
Year Published: 2022

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.